Each week, many millions are invested into life sciences startups. There are so many that often, they get lost in the weeds. We’re keeping track for you – based on regulatory filings reported to the SEC. Here are the new funding notices from Oct. 24 to 30: Biotech Aileron Therapeutics – Cambridge, Massachusetts $33 million in equity raised, […]
Most devices that treat sleep apnea are in the form of high-tech, oxygenated face masks – but a Minnesota startup is taking a different approach, building an implantable device that treats the common breathing disorder. Respicardia has raised $25 million, with about $20 million of that coming from the Milan-based Sorin Group. The Italian cardiac devicemaker which […]
Zelis CEO Amanda Eisel shares her perspective on how the company is solving the problems of a fragmented health financial system to benefit all.
Though lots of venture capital for medtech has evaporated, Versant Ventures now seeks $250 million for its fifth medtech fund. The venture capital firm, which has strong presence in biotech and medtech, has a diverse California and Minnesota-based portfolio that includes medical device companies such as Respicardia, Zyga Technology and Autonomic Technologies. According to a […]
For the past six years, Minnesota device startup Respicardia has been trying to commercialize a product that President and CEO Bonnie Labosky believes has no rival worldwide. It is an implantable device, the size of a pacemaker, that can be placed in the right or left side of chest to treat the problem of central […]